Study Reveals Brain Signature of Depressed Mood
Do new findings provide an initial line of evidence indicating the feasibility of mood state decoding linked to brain signature? For the first time, researchers have identified what appears to be ...
Category : Neuroscience
Brain Research Foundation Statement About Paul Allen, Founder The Allen Institute for Brain Research
The Brain Research Foundation community mourns the passing of Paul Allen, founder of The Allen Institute for Brain Research and distinguished business pioneer as co-founder of Microsoft and others. In its ...
Brain & Behavior Research Foundation Names 10 New Members to Scientific Council
Council Reviews Grant Applications for the Nation’s Top Non-Governmental Funder of Mental Health Research Grants, $394 Million Awarded Since 1987 The Brain & Behavior Research Foundation has named 10 new ...
Doctors And Machines Combine Intelligence To Prevent Deadly Lung Failure
$1.2 Million Government Grant Will Allow Montefiore Einstein to Advance Use of Artificial Intelligence in Hospitals A new artificial intelligence (AI) tool is being built to help doctors better identify ...
COMPASS Pathways Receives FDA Breakthrough Therapy Designation for Psilocybin Therapy for Treatment-resistant Depression
COMPASS Pathways, a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health, has received Breakthrough Therapy designation from the US Food and Drug Administration (FDA) ...
Bioscience Pharma Partners, LLC (BPP) Announces Receipt of Key Patent, Appointment of Senior Executive, Engagement of PharmaVentures Ltd. and Participation at BioEurope 2018
Bioscience Pharma Partners (“BPP”) announced that it has been granted a patent by the U.S. Patent and Trademark Office (USPTO) for the use of its 5-Lipoxygenase activating protein (FLAP) inhibitor, ...
AbbVie to Assume Full Development and Commercial Control of Cystic Fibrosis Research Program
AbbVie a research-based global biopharmaceutical company, announced that it will assume full development and commercial responsibility for its collaboration with Galapagos (Euronext: GLPG) to discover and develop new therapies to ...
United Neuroscience to Present Alzheimer’s Vaccine Clinical Trial Update at CTAD 2018
Lead Program on Track for Phase IIa Clinical Data Announcement Before Year-End United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brain ...
United Neuroscience Continues Growth with Addition of Five Executives to Management Team
United Neuroscience, Ltd., (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brain disorders, announced five executive appointments as part of the company’s continued ...
Stoke Med to Provide Patient Specific 3D-Printed Models
Reduce Cost and Increase Safety for Routine and Complex Surgical Procedures Stoke Ventures, a company leading the way in product launch services is excited to announce their latest venture, Stoke ...